Teva Pharmaceutical Industries Ltd

자세한 내용은 Teva Pharmaceutical Industries Ltd 회사

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

회사 정보

종목 코드 TEVA

회사 이름Teva Pharmaceutical Industries Ltd

상장일Jan 01, 1951

CEOMr. Richard D. Francis

직원 수33892

유형Ordinary Share

회계 연도 종료Jan 01

주소124 Dvora Hanevi'a St.

도시TEL AVIV-YAFO

증권 거래소Tel Aviv Stock Exchange

국가Israel

우편 번호6944020

전화97239148213

웹사이트https://www.tevapharm.com/

종목 코드 TEVA

상장일Jan 01, 1951

CEOMr. Richard D. Francis

회사 임원

이름

이름/직위

직위

주식 보유

변동

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Eliyahu Sharon (Eli) Kalif

Chief Financial Officer, Executive Vice President

--

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. Chen Lichtenstein

Independent Director

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

이름

이름/직위

직위

주식 보유

변동

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Generic products

2.31B

59.26%

AUSTEDO

411.00M

10.56%

Anda

373.00M

9.59%

Other

220.00M

5.65%

AJOVY

139.00M

3.57%

Other

442.00M

11.36%

지역별USD

이름

수익

비율

United States

1.91B

49.06%

Europe

1.19B

30.69%

International Markets

582.00M

14.96%

Other

205.00M

5.27%

사업별

지역별

사업별USD

이름

수익

비율

Generic products

2.31B

59.26%

AUSTEDO

411.00M

10.56%

Anda

373.00M

9.59%

Other

220.00M

5.65%

AJOVY

139.00M

3.57%

Other

442.00M

11.36%

주식 보유 통계

마지막 업데이트: Sat, Jul 12

주주

주주 유형

주주

비율

Fidelity Management & Research Company LLC

6.56%

Menora Mivtachim Insurance Ltd.

5.00%

Ion Asset Management Israel Ltd

3.40%

Clal Insurance Enterprises Holdings Ltd.

3.29%

Phoenix Investment and Finances Ltd

3.29%

Other

78.44%

주주

비율

Fidelity Management & Research Company LLC

6.56%

Menora Mivtachim Insurance Ltd.

5.00%

Ion Asset Management Israel Ltd

3.40%

Clal Insurance Enterprises Holdings Ltd.

3.29%

Phoenix Investment and Finances Ltd

3.29%

Other

78.44%

주주 유형

주주

비율

Investment Advisor

27.60%

Hedge Fund

13.28%

Investment Advisor/Hedge Fund

11.76%

Insurance Company

7.31%

Research Firm

2.85%

Pension Fund

1.82%

Family Office

1.32%

Bank and Trust

0.82%

Sovereign Wealth Fund

0.22%

Other

33.01%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

1097

737.27M

64.27%

-2.94M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

2023Q2

921

512.98M

45.79%

-122.32M

2023Q1

927

576.84M

51.93%

-50.26M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Fidelity Management & Research Company LLC

75.30M

6.57%

-710.45K

-0.93%

Mar 31, 2025

Menora Mivtachim Insurance Ltd.

29.19M

2.55%

+808.07K

+2.85%

Mar 31, 2025

Ion Asset Management Israel Ltd

39.03M

3.4%

+2.38M

+6.50%

Mar 31, 2025

Clal Insurance Enterprises Holdings Ltd.

37.79M

3.3%

-1.17M

-3.00%

Mar 31, 2025

Phoenix Investment and Finances Ltd

27.46M

2.39%

+6.25M

+29.47%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

33.06M

2.88%

-39.31K

-0.12%

Mar 31, 2025

Lingotto Investment Management LLP

27.85M

2.43%

+661.55K

+2.43%

Mar 31, 2025

Migdal Insurance and Financial Holdings Ltd

26.34M

2.3%

+300.00K

+1.15%

Mar 31, 2025

Rubric Capital Management LP

25.55M

2.23%

+8.55M

+50.29%

Mar 31, 2025

Harel Insurance Investments and Financial Services Ltd

22.06M

1.92%

+22.04M

+197885.16%

Mar 31, 2025

15.545USD

Teva Pharmaceutical Industries Ltd

15.545

개요

회사

금융